Clinical Trials

55 enrolled

Astrocytoma, Glioma, Oligodendroglioma

NCT03911388 2026-02-17

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Phase 1 Recruiting

24 enrolled

CNSSarcoma

Choroid Plexus Carcinoma, Astrocytoma, Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, Cerebellar Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Nervous System Diseases, Nervous System Neoplasms, Oligodendroglioma, Virus Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Gliosarcoma, Rhabdoid Tumor

NCT05331521 2026-02-03

ImproveCodel

Phase 3 Recruiting

406 enrolled

Oligodendroglioma

NCT04702581 2026-01-29

POLO

Phase 3 Recruiting

280 enrolled

Oligodendroglioma

NCT04623931 2026-01-14

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

40 enrolled

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT04541082 2025-12-18

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Phase 1 Recruiting

102 enrolled

CNSSarcoma

Typical Teratoid Rhabdoid Tumor, Astrocytoma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Gliosarcoma

NCT05956821 2025-12-08

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Phase 1/2 Recruiting

20 enrolled

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Oligodendroglioma

NCT06930846 2025-11-21

HOBSCOTCH-CA

125 enrolled

Caregiver Burden, Brain Neoplasms, Memory Disorders, Meningioma, Oligodendroglioma, Cognitive Dysfunction

NCT06989086 2025-09-09

FearLess in NeuroOncology

112 enrolled

Astrocytoma, Brain Neoplasms, Glioblastoma, Oligodendroglioma

NCT07159607 2025-09-08

APPEAR

Recruiting

100 enrolled

Phase EARLY_PHASE1 Recruiting

Astrocytoma, Glioma, Oligodendroglioma

NCT04135807 2025-07-23

Implantable Microdevice In Primary Brain Tumors

12 enrolled

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT06108206 2025-07-03

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

20 enrolled

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT05698524 2025-05-20

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Phase 1 Recruiting

24 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT06161974 2025-02-21

Study of Olutasidenib and Temozolomide in HGG

60 enrolled

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Spinal Cord Neoplasms

NCT05190172 2025-02-12

PRO-GLIO

225 enrolled

Astrocytoma, Oligodendroglioma

NCT04648462 2024-11-26

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Recruiting

1,500 enrolled

Adenoma, Astrocytoma, Craniopharyngioma, Ependymoma, Hemangiopericytoma, Meningioma, Neurilemmoma, Oligodendroglioma, Germinoma, Ganglioglioma, Nerve Sheath Neoplasms, Optic Nerve Glioma

NCT05512351 2022-09-27

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma

80 enrolled

Oligodendroglioma

NCT01649830 2020-05-28

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Phase 3 Recruiting

290 enrolled